Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era

MLA

Hamish Innes, et al. Prognosis of 1169 Hepatitis C Chronically Infected Patients with Decompensated Cirrhosis in the Predirect-Acting Antiviral Era. Nov. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1148f4134ae89a1dcb84a35b0a9683e9&authtype=sso&custid=ns315887.

APA

Hamish Innes, Peter C. Hayes, Sharon J. Hutchinson, Scott A. McDonald, Maryam Alavi, David J. Goldberg, Esther J. Aspinall, & Heather Valerio. (2016). Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era.

Chicago

Hamish Innes, Peter C. Hayes, Sharon J. Hutchinson, Scott A. McDonald, Maryam Alavi, David J. Goldberg, Esther J. Aspinall, and Heather Valerio. 2016. “Prognosis of 1169 Hepatitis C Chronically Infected Patients with Decompensated Cirrhosis in the Predirect-Acting Antiviral Era,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1148f4134ae89a1dcb84a35b0a9683e9&authtype=sso&custid=ns315887.